As a Free StocksGuide user, you can view scores for all 7,084 stocks worldwide.
12 Analysts have issued a MediWound Ltd. forecast:
12 Analysts have issued a MediWound Ltd. forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 21 21 |
6%
6%
|
|
| Gross Profit | 3.88 3.88 |
58%
58%
|
|
| EBITDA | -22 -22 |
40%
40%
|
|
| EBIT (Operating Income) EBIT | -24 -24 |
37%
37%
|
|
| Net Profit | -21 -21 |
26%
26%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
MediWound Ltd. is a biopharmaceutical company engaging in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in 2001 and is headquartered in Yavne, Israel.
| Head office | Israel |
| CEO | Ofer Gonen |
| Employees | 111 |
| Founded | 2000 |
| Website | www.mediwound.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


